Overview

Drug-drug Interaction Study of SPH3127

Status:
Active, not recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
A single center, open-label, fixed sequence Phase 1, drug-drug interaction (DDI) study in male healthy subjects.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co., Ltd
Treatments:
Itraconazole
Rifampin